Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.

Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin.

BACKGROUND:The current stopping rule for peginterferon/ribavirin therapy in hepatitis C virus genotype-1 (HCV-1) patients is based on an early virological response (EVR, defined as >2 log(10) viral reduction at treatment week 12). We aimed to explore rapid stopping rules at week 4. METHODS:We ran...

Full description

Bibliographic Details
Main Authors: Ming-Lung Yu, Chen-Hua Liu, Chung-Feng Huang, Tai-Chung Tseng, Jee-Fu Huang, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Liang-Yen Wang, Suh-Hang Hank Juo, Wan-Long Chuang, Jia-Horng Kao
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3528729?pdf=render

Internet

http://europepmc.org/articles/PMC3528729?pdf=render

Similar Items